Skip to main content
Clinical Trials/ITMCTR2100005016
ITMCTR2100005016
Not yet recruiting
Phase 1

Effects of electroacupuncture in the treatment of chronic spontaneous urticaria (CSU) : a randomized controlled trial

Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
chronic spontaneous urticaria
Sponsor
Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with chronic spontaneous urticaria with clinical diagnosis of traditional Chinese and Western medicine;
  • 2\. Aged between 18\-65 years, no gender limit;
  • 3\. No serious heart, liver, lung, kidney and metabolic diseases;
  • 4\. Have not received corticosteroids, non\-steroids, antihistamines, immunosuppressants and biological agents recently (within 1 month);
  • 5\. Disease duration \> 6 weeks;
  • 6\. Those who voluntarily participate in this experiment, can obey the treatment plan, and sign the informed consent.

Exclusion Criteria

  • 1\. Those who have infectious skin diseases, or who have infection, ulcers or scars on the skin of the treatment site;
  • 2\. Pregnancy and lactation patients;
  • 3\. Patients with malignant tumor, or spontaneous bleeding tendency such as thrombocytopenia and hemophilia;
  • 4\. Patients with serious primary diseases such as cerebrovascular, autoimmune diseases or hematopoietic system, mental patients or combined with secondary infection;
  • 5\. Patients with severe acute exacerbation of chronic urticaria, such as chest tightness, wheezing, dyspnea involving the laryngeal mucosa, and life\-threatening suffocation due to laryngeal edema; those with systemic symptoms such as high fever, chills, and rapid pulse;
  • 6\. Those who are participating in other clinical trials or who have participated in other clinical trials within 12 weeks;
  • 7\. Patients who are not suitable for inclusion in the group according to the judgment of the doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials